Selected article for: "antibiotic therapy and significant difference"

Author: Xiaoping Chen; Qunqun Jiang; Zhiyong Ma; Jiaxin Ling; Wenjia Hu; Qian Cao; Pingzheng Mo; Rongrong Yang; Shicheng Gao; Xien Gui; Yong Xiong; Jinlin Li; Yongxi Zhang
Title: Clinical Characteristics of Hospitalized Patients with SARS-CoV-2 and Hepatitis B virus Co-infection
  • Document date: 2020_3_27
  • ID: 5pfusktn_27
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101 /2020 The treatment was mainly the supportive care (Table 1) . Seventy-four patients were given antiviral (arbidol, orally, 200 mg, three times per day), and 74 with oxygen support. Antibiotic therapy, both orally and intravenous, were given as described in Table 1 . Sixty-one patients received corticosteroids to suppress an excessive inflammato.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10. 1101 /2020 The treatment was mainly the supportive care (Table 1) . Seventy-four patients were given antiviral (arbidol, orally, 200 mg, three times per day), and 74 with oxygen support. Antibiotic therapy, both orally and intravenous, were given as described in Table 1 . Sixty-one patients received corticosteroids to suppress an excessive inflammatory activation. There is no significant difference of treatment between patients with or without HBV infection.

    Search related documents:
    Co phrase search for related documents
    • antibiotic therapy and day time: 1, 2, 3, 4
    • antibiotic therapy and inflammatory activation: 1, 2
    • antibiotic therapy and oxygen support: 1, 2, 3, 4, 5, 6, 7, 8
    • antibiotic therapy and patient treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
    • antibiotic therapy and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • antibiotic therapy and supportive care: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • antiviral arbidol and day time: 1, 2
    • antiviral arbidol and inflammatory activation: 1
    • antiviral arbidol and oxygen support: 1
    • antiviral arbidol and patient treatment: 1, 2
    • antiviral arbidol and significant difference: 1, 2, 3, 4, 5
    • antiviral arbidol and supportive care: 1, 2
    • corticosteroid receive and patient corticosteroid receive: 1, 2
    • corticosteroid receive and patient treatment: 1, 2
    • corticosteroid receive and significant difference: 1, 2, 3
    • day time and inflammatory activation: 1, 2
    • day time and oxygen support: 1, 2, 3, 4, 5
    • day time and patient treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • day time and significant difference: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61